Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points.
Torres A, Rank D, Melnick D, Rekeda L, Chen X, Riccobene T, Critchley IA, Lakkis HD, Taylor D, Talley AK. Torres A, et al. Among authors: riccobene t. Open Forum Infect Dis. 2019 Apr 25;6(4):ofz149. doi: 10.1093/ofid/ofz149. eCollection 2019 Apr. Open Forum Infect Dis. 2019. PMID: 31041348 Free PMC article.
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.
Das S, Li J, Riccobene T, Carrothers TJ, Newell P, Melnick D, Critchley IA, Stone GG, Nichols WW. Das S, et al. Among authors: riccobene t. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02187-18. doi: 10.1128/AAC.02187-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670413 Free PMC article. Review.
Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam.
Li J, Lovern M, Riccobene T, Carrothers TJ, Newell P, Das S, Talley AK, Tawadrous M. Li J, et al. Among authors: riccobene t. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02105-19. doi: 10.1128/AAC.02105-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015049 Free PMC article. Review.
Avibactam Pharmacokinetic/Pharmacodynamic Targets.
Nichols WW, Newell P, Critchley IA, Riccobene T, Das S. Nichols WW, et al. Among authors: riccobene t. Antimicrob Agents Chemother. 2018 May 25;62(6):e02446-17. doi: 10.1128/AAC.02446-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29610208 Free PMC article. Review.
Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae.
Van Wart SA, Ambrose PG, Rubino CM, Khariton T, Riccobene TA, Friedland HD, Critchley IA, Bhavnani SM. Van Wart SA, et al. Among authors: riccobene ta. Antimicrob Agents Chemother. 2014;58(2):885-91. doi: 10.1128/AAC.01680-13. Epub 2013 Nov 25. Antimicrob Agents Chemother. 2014. PMID: 24277021 Free PMC article.
48 results